No black box warning on record for Raxibacumab

As of the latest FDA labeling reviewed, Raxibacumab (RAXIBACUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Raxibacumab medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity and Anaphylaxis: ( Boxed Warning , 2.1 , 2.3 , 5.1 , 6.1 ) 5.1 Hypersensitivity and Anaphylaxis Hypersensitivity reactions including rash, urticaria, pruritus, chills, chest and throat tightness, lip and throat swelling, and hypotension were reported in 27 (4.5%) of 606 healthy subjects during or after the administration of raxibacumab in clinical trials

No black box warning on record for Raxibacumab

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity and Anaphylaxis: ( Boxed Warning , 2.1 , 2.3 , 5.1 , 6.1 ) 5.1 Hypersensitivity and Anaphylaxis Hypersensitivity reactions including rash, urticaria, pruritus, chills, chest and throat tightness, lip and throat swelling, and hypotension were reported in 27 (4.5%) of 606 healthy subjects during or after the administration of raxibacumab in clinical trials

Raxibacumab Black Box Warning

No black box warning on record for Raxibacumab

Other warnings & precautions

Raxibacumab Black Box Warning

No black box warning on record for Raxibacumab

Other warnings & precautions